{"name":"Nanjing NingQi Medicine Science and Technology Co., Ltd.","slug":"nanjing-ningqi-medicine-science-and-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Huangqi-Guizhi-Wuwu granules","genericName":"Huangqi-Guizhi-Wuwu granules","slug":"huangqi-guizhi-wuwu-granules","indication":"Cardiovascular disease or heart failure (traditional indication based on classical Chinese medicine formulation)","status":"phase_3"},{"name":"Changchun marina","genericName":"Changchun marina","slug":"changchun-marina","indication":"Atrial fibrillation for stroke prevention","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Danggui-Sini granules","genericName":"Danggui-Sini granules","slug":"danggui-sini-granules","indication":"Cold-related pain conditions","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"parapl","genericName":"parapl","slug":"parapl","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Huangqi-Guizhi-Wuwu granules","genericName":"Huangqi-Guizhi-Wuwu granules","slug":"huangqi-guizhi-wuwu-granules","phase":"phase_3","mechanism":"Huangqi-Guizhi-Wuwu granules is a traditional Chinese medicine formulation that enhances immune function and improves microcirculation to support cardiovascular health.","indications":["Cardiovascular disease or heart failure (traditional indication based on classical Chinese medicine formulation)"],"catalyst":""},{"name":"Changchun marina","genericName":"Changchun marina","slug":"changchun-marina","phase":"marketed","mechanism":"Changchun marina is a medication used to treat atrial fibrillation.","indications":["Atrial fibrillation for stroke prevention"],"catalyst":""},{"name":"Danggui-Sini granules","genericName":"Danggui-Sini granules","slug":"danggui-sini-granules","phase":"phase_3","mechanism":"Danggui-Sini granules is a traditional Chinese medicine formulation that promotes blood circulation and warms the meridians to treat cold-related pain and circulatory dysfunction.","indications":["Cold-related pain conditions","Peripheral circulatory dysfunction","Raynaud's phenomenon or similar cold extremity conditions"],"catalyst":""},{"name":"parapl","genericName":"parapl","slug":"parapl","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":2,"marketed":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}